Annual Current Liabilities
$6.59 M
+$207.00 K+3.24%
December 31, 2023
Summary
- As of February 7, 2025, LSTA annual total current liabilities is $6.59 million, with the most recent change of +$207.00 thousand (+3.24%) on December 31, 2023.
- During the last 3 years, LSTA annual current liabilities has risen by +$3.08 million (+87.96%).
- LSTA annual current liabilities is now -81.92% below its all-time high of $36.45 million, reached on December 1, 2011.
Performance
LSTA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$4.69 M
+$234.00 K+5.25%
September 30, 2024
Summary
- As of February 7, 2025, LSTA quarterly total current liabilities is $4.69 million, with the most recent change of +$234.00 thousand (+5.25%) on September 30, 2024.
- Over the past year, LSTA quarterly current liabilities has dropped by -$1.90 million (-28.82%).
- LSTA quarterly current liabilities is now -90.70% below its all-time high of $50.44 million, reached on September 1, 2012.
Performance
LSTA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
LSTA Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.2% | -28.8% |
| 3 y3 years | +88.0% | -28.8% |
| 5 y5 years | +17.3% | -28.8% |
LSTA Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +45.7% | -28.8% | +67.5% |
| 5 y | 5-year | at high | +88.0% | -28.8% | +67.5% |
| alltime | all time | -81.9% | +2437.5% | -90.7% | +1488.0% |
Lisata Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.69 M(+5.3%) |
| Jun 2024 | - | $4.46 M(-16.4%) |
| Mar 2024 | - | $5.33 M(-19.1%) |
| Dec 2023 | $6.59 M(+3.2%) | $6.59 M(+28.4%) |
| Sep 2023 | - | $5.13 M(+17.8%) |
| Jun 2023 | - | $4.36 M(-17.6%) |
| Mar 2023 | - | $5.29 M(-17.2%) |
| Dec 2022 | $6.38 M(+41.1%) | $6.38 M(-0.1%) |
| Sep 2022 | - | $6.39 M(+90.4%) |
| Jun 2022 | - | $3.36 M(+19.9%) |
| Mar 2022 | - | $2.80 M(-38.1%) |
| Dec 2021 | $4.52 M(+29.0%) | - |
| Dec 2021 | - | $4.52 M(+11.1%) |
| Sep 2021 | - | $4.07 M(+5.6%) |
| Jun 2021 | - | $3.86 M(-13.1%) |
| Mar 2021 | - | $4.44 M(+26.6%) |
| Dec 2020 | $3.51 M(-41.3%) | $3.51 M(-16.1%) |
| Sep 2020 | - | $4.18 M(+20.1%) |
| Jun 2020 | - | $3.48 M(-24.7%) |
| Mar 2020 | - | $4.62 M(-22.7%) |
| Dec 2019 | $5.98 M(+6.4%) | $5.98 M(-0.1%) |
| Sep 2019 | - | $5.98 M(+4.7%) |
| Jun 2019 | - | $5.71 M(+12.0%) |
| Mar 2019 | - | $5.10 M(-9.2%) |
| Dec 2018 | $5.62 M(-39.7%) | $5.62 M(+14.9%) |
| Sep 2018 | - | $4.89 M(-16.1%) |
| Jun 2018 | - | $5.83 M(-26.8%) |
| Mar 2018 | - | $7.96 M(-14.6%) |
| Dec 2017 | $9.31 M(-56.0%) | $9.31 M(-18.1%) |
| Sep 2017 | - | $11.37 M(-21.8%) |
| Jun 2017 | - | $14.55 M(-37.3%) |
| Mar 2017 | - | $23.21 M(+9.6%) |
| Dec 2016 | $21.18 M(+0.8%) | $21.18 M(+14.2%) |
| Sep 2016 | - | $18.55 M(-17.0%) |
| Jun 2016 | - | $22.36 M(+21.1%) |
| Mar 2016 | - | $18.46 M(-12.1%) |
| Dec 2015 | $21.02 M(+29.4%) | $21.02 M(+6.5%) |
| Sep 2015 | - | $19.74 M(+20.9%) |
| Jun 2015 | - | $16.33 M(-6.5%) |
| Mar 2015 | - | $17.46 M(+7.5%) |
| Dec 2014 | $16.24 M(+65.6%) | $16.24 M(+37.0%) |
| Sep 2014 | - | $11.85 M(-0.5%) |
| Jun 2014 | - | $11.91 M(+35.6%) |
| Mar 2014 | - | $8.79 M(-10.4%) |
| Dec 2013 | $9.81 M(-1.4%) | $9.81 M(-2.3%) |
| Sep 2013 | - | $10.04 M(+19.7%) |
| Jun 2013 | - | $8.38 M(-9.1%) |
| Mar 2013 | - | $9.23 M(-7.2%) |
| Dec 2012 | $9.95 M(-72.7%) | $9.95 M(-80.3%) |
| Sep 2012 | - | $50.44 M(+5.0%) |
| Jun 2012 | - | $48.02 M(+1.9%) |
| Mar 2012 | - | $47.14 M(+29.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $36.45 M(+11.0%) | $36.45 M(+15.6%) |
| Sep 2011 | - | $31.52 M(-18.7%) |
| Jun 2011 | - | $38.77 M(-5.3%) |
| Mar 2011 | - | $40.95 M(+24.7%) |
| Dec 2010 | $32.84 M(+30.2%) | $32.84 M(+59.7%) |
| Sep 2010 | - | $20.57 M(-22.9%) |
| Jun 2010 | - | $26.68 M(-14.4%) |
| Mar 2010 | - | $31.17 M(+23.6%) |
| Dec 2009 | $25.22 M(+2524.5%) | $25.22 M(+841.3%) |
| Sep 2009 | - | $2.68 M(+183.9%) |
| Jun 2009 | - | $944.00 K(-63.9%) |
| Mar 2009 | - | $2.62 M(+172.1%) |
| Dec 2008 | $961.10 K(+116.4%) | $961.10 K(+109.8%) |
| Sep 2008 | - | $458.10 K(+55.1%) |
| Jun 2008 | - | $295.40 K(-25.0%) |
| Mar 2008 | - | $393.80 K(-11.3%) |
| Dec 2007 | $444.20 K(-47.0%) | $444.20 K(+24.3%) |
| Sep 2007 | - | $357.40 K(-54.5%) |
| Jun 2007 | - | $785.90 K(+51.0%) |
| Mar 2007 | - | $520.40 K(-37.9%) |
| Dec 2006 | $838.30 K(-52.2%) | $838.30 K(+52.8%) |
| Sep 2006 | - | $548.80 K(-79.4%) |
| Jun 2006 | - | $2.66 M(+57.5%) |
| Mar 2006 | - | $1.69 M(-3.5%) |
| Dec 2005 | $1.75 M(+36.1%) | $1.75 M(-6.4%) |
| Sep 2005 | - | $1.87 M(+15.0%) |
| Jun 2005 | - | $1.63 M(+15.5%) |
| Mar 2005 | - | $1.41 M(+9.4%) |
| Dec 2004 | $1.29 M(+25.9%) | $1.29 M(-10.5%) |
| Sep 2004 | - | $1.44 M(+17.9%) |
| Jun 2004 | - | $1.22 M(+1.8%) |
| Mar 2004 | - | $1.20 M(+17.2%) |
| Dec 2003 | $1.02 M(-10.4%) | $1.02 M(+0.4%) |
| Sep 2003 | - | $1.02 M(-34.4%) |
| Jun 2003 | - | $1.55 M(+19.9%) |
| Mar 2003 | - | $1.30 M(+13.5%) |
| Dec 2002 | $1.14 M(+133.1%) | $1.14 M(+8.8%) |
| Sep 2002 | - | $1.05 M(+37.9%) |
| Jun 2002 | - | $760.80 K(+30.7%) |
| Mar 2002 | - | $582.20 K(+18.9%) |
| Dec 2001 | $489.50 K(+6.8%) | $489.50 K(+7.4%) |
| Sep 2001 | - | $455.80 K(+5.3%) |
| Jun 2001 | - | $432.90 K(+2.9%) |
| Mar 2001 | - | $420.80 K(-8.2%) |
| Dec 2000 | $458.40 K(-47.5%) | $458.40 K(-9.0%) |
| Sep 2000 | - | $503.50 K(+0.8%) |
| Jun 2000 | - | $499.30 K(+19.1%) |
| Mar 2000 | - | $419.30 K |
| Dec 1999 | $872.90 K(+132.4%) | - |
| Dec 1998 | $375.60 K(+44.6%) | - |
| Mar 1998 | $259.70 K(-61.0%) | - |
| Mar 1997 | $666.60 K(+46.4%) | - |
| Mar 1996 | $455.30 K | - |
FAQ
- What is Lisata Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Lisata Therapeutics?
- What is Lisata Therapeutics annual current liabilities year-on-year change?
- What is Lisata Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Lisata Therapeutics?
- What is Lisata Therapeutics quarterly current liabilities year-on-year change?
What is Lisata Therapeutics annual total current liabilities?
The current annual current liabilities of LSTA is $6.59 M
What is the all time high annual current liabilities for Lisata Therapeutics?
Lisata Therapeutics all-time high annual total current liabilities is $36.45 M
What is Lisata Therapeutics annual current liabilities year-on-year change?
Over the past year, LSTA annual total current liabilities has changed by +$207.00 K (+3.24%)
What is Lisata Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of LSTA is $4.69 M
What is the all time high quarterly current liabilities for Lisata Therapeutics?
Lisata Therapeutics all-time high quarterly total current liabilities is $50.44 M
What is Lisata Therapeutics quarterly current liabilities year-on-year change?
Over the past year, LSTA quarterly total current liabilities has changed by -$1.90 M (-28.82%)